Author

J. Piñana

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Magnusiomyces Capitatus Breakthrough Infection in Allogeneic Hematopoietic Cell Transplant Recipients Receiving Echinocandin Prophylaxis: Clinical Features, Management, and Structured Review of the Literature

Magnusiomyces spp. infections are an uncommon but highly lethal emerging mycosis in immunocompromised patients, particularly those with hematologic malignancies and profound neutropenia. Data in the setting of allogeneic hematopoietic cell transplantation (allo-HCT) remain scarce. These infections typically occur early...

Claudia Gómez-Hernández, C. Corrales, P. Mirete et al. · Mediterranean Journal of Hem... · 0 citations

Open access Sep 2026

Hypophosphatemia after CAR-T cell therapy: a prospective study of inflammation, tubular injury and phosphate handling.

Background Hypophosphatemia is a frequent electrolyte abnormality after chimeric antigen receptor T-cell (CAR-T) therapy, but the clinical and biological factors associated with phosphate decline remain poorly defined. We prospectively evaluated the incidence, determinants, and potential biological associations of hypo...

Francesc Moncho-Francés, R. Hernani, Miguel Angel Solis-Salguero et al. · Clinical Kidney Journal · 0 citations

Open access Aug 2026

Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy

Simple Summary Natural killer cells are promising candidates for cellular therapy after allogeneic hematopoietic stem cell transplantation because they can help control malignant cells and viral infections with a low risk of graft-versus-host disease. However, the ability to manufacture these cells consistently under g...

Rut Meseguer, Cristóbal Aguilar, P. Amat et al. · Cancers · 0 citations